Along with unexpected benefits, medical specialists in South Florida also see patients grappling with the drawbacks of GLP-1 ...

GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, ...

Emerging research suggests that taking most blood pressure medications at night, rather than in the morning, could significantly reduce risks of stroke, heart attack, and heart failure. The approach, ...

Insurers are putting a growing focus on specialty drugs covered under the medical benefit, and on re-evaluating the efficacy ...

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

University of Miami researchers found that type 2 diabetes drug metformin can help cancer patients by activating a molecule ...

PSG’s research found that payers are placing more attention on specialty drugs covered under the medical benefit, showing ...

Researchers suggest that a simple explanation of the benefits and harms of a medication could improve a patient’s drug of choice, according to a Dartmouth College release. Previous research suggests ...

A comprehensive review of meta-analyses and clinical studies confirms GLP-1 receptor agonists, first developed for type 2 diabetes, offer benefits across cardiovascular, metabolic, renal, respiratory, ...

Editor’s note: Kathy Chang is the head of trade relations at health plan Blue Shield of California. The U.S. prescription drug market produces some of the world’s most advanced pharmaceutical ...

Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market ...